^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    PEP07

    i
    Other names: PEP07, SOL-578
    Associations

    News

    Trials
    Company:
    PharmaEngine, Sentinel Oncology
    Drug class:
    Chk1 inhibitor
    Related drugs:
    Associations

    News

    Trials
    1m
    A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients with Advanced or Metastatic Solid Tumors (clinicaltrials.gov)
    P1, N=54, Recruiting, PharmaEngine | Not yet recruiting --> Recruiting | Trial completion date: Dec 2026 --> Aug 2027 | Trial primary completion date: Jul 2026 --> Feb 2027
    Enrollment open • Trial completion date • Trial primary completion date • Metastases
    |
    PEP07
    6ms
    A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer (clinicaltrials.gov)
    P1, N=32, Recruiting, PharmaEngine | Phase classification: P1b --> P1
    Phase classification • Metastases
    |
    PEP07
    over1year
    A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer (clinicaltrials.gov)
    P1b, N=32, Recruiting, PharmaEngine | Not yet recruiting --> Recruiting | Initiation date: Mar 2023 --> Jul 2023
    Enrollment open • Trial initiation date • Metastases
    |
    PEP07